skip to primary navigationskip to content
 

10.05.16 Steve Jackson wins the 2016 Dr A.H. Heineken Prize for Medicine

last modified May 10, 2016 11:19 AM
The Gurdon Institute's Steve Jackson, Quick Professor of Biology at the University of Cambridge and the Institute's head of Cancer Research UK Laboratories, has won the 2016 Heineken Prize for Medicine.
10.05.16  Steve Jackson wins the 2016 Dr A.H. Heineken Prize for Medicine

Steve Jackson [photo credit KNAW/Jussi Puikkonen].

Professor Steve Jackson will receive the prestigious Dr A.H. Heineken Prize for Medicine, value $200,000, for his "fundamental research into DNA repair in human cells and for the successful application of knowledge of that process in the development of new cancer drugs".

The prize is conferred by the Royal Netherlands Academy of Arts and Sciences, along with others in Biochemistry and Biophysics, Environmental Sciences, Cognitive Science, History and Art.

The Heineken Prizes are the largest international research prizes in the Netherlands and are awarded every other year. The winners are selected by juries consisting of leading international researchers put together by the Academy.

The prizes are named after Dr Henry P. Heineken (1886-1971), Dr Alfred H. Heineken (1923-2002) and Charlene de Carvalho-Heineken (1954-). Charlene de Carvalho-Heineken is chair of the Dr H.P. Heineken Foundation and the Alfred Heineken Fondsen Foundation, which finance the prizes. 

"It is a great honour and privilege to receive the 2016 Dr A.H. Heineken Prize for Medicine," said Jackson, adding: "I would like to thank all the many dedicated, innovative and highly talented people who have worked in my laboratory, as it is their groundbreaking science that has led to me receiving this award. I also express my deepest thanks to my mentors and inspirational colleagues in the Gurdon Institute at Cambridge University for their invaluable support and advice over the years."

The prize-giving ceremony will take place in September 2016 in Amsterdam's Stock Exchange building, the Beurs van Berlage, now a grand venue for municipal events and conferences.

 

More about research in the Jackson group.

Studying development to understand disease

The Gurdon Institute is funded by Wellcome and Cancer Research UK to study the biology of development, and how normal growth and maintenance go wrong in cancer and other diseases.

combinedLogo x3 trans2018

 

Share this

Integrin signaling downregulates filopodia in muscle-tendon attachment

Defining Lineage Potential and Fate Behavior of Precursors during Pancreas Development

DDX3X RNA helicase affects breast cancer cell cycle progression by regulating expression of KLF4

Natural Genetic Variation in a Multigenerational Phenotype in C. elegans

On the origin of the human germline

Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells 

Genome-Scale Oscillations in DNA Methylation during Exit from Pluripotency

Immune Cell Dynamics Unfolded by Single-Cell Technologies

Chromatin Accessibility Impacts Transcriptional Reprogramming in Oocytes

Integrin α2 marks a niche of trophoblast progenitor cells in first trimester human placenta

Inhibition of the acetyltransferase NAT10 normalizes progeric and aging cells by rebalancing the Transportin-1 nuclear import pathway

SLAM-ITseq: Sequencing cell type-specific transcriptomes without cell sorting

SRSF3 maintains transcriptome integrity in oocytes by regulation of alternative splicing and transposable elements

scmap: projection of single-cell RNA-seq data across data sets

Single-cell transcriptomics reveals a new dynamical function of transcription factors during embryonic hematopoiesis

Map of synthetic rescue interactions for the Fanconi anemia DNA repair pathway identifies USP48

The developmental origin of brain tumours: a cellular and molecular framework

 

 

Link to full list on PubMed